3171 - 3180 of 8587 Results
Title
Year
-
OPENTitle: Analysis of Mitochondrial haemoglobin in Parkinson's disease brainJournal Name: MitochondrionPublisher: Elsevier BVVol: 29Issue #:Start Page: 45End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001Best OA location URL: https://doi.org/10.1016/j.mito.2016.05.001Citation Count: 26
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial2017OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Citation Count: 690
-
OPENTitle: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 9Start Page: 2480End Page: 2492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awu179Best OA location URL: https://academic.oup.com/brain/article-pdf/137/9/2480/13798270/awu179.pdfCitation Count: 180
- Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)2016OPENTitle: Loss-of-function mutations in theATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 2Start Page: 287End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww307Best OA location URL: https://academic.oup.com/brain/article-pdf/140/2/287/24174630/aww307.pdfCitation Count: 152
- O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease2015OPENTitle: O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseJournal Name: Nature ChemistryPublisher: Springer Science and Business Media LLCVol: 7Issue #: 11Start Page: 913End Page: 920Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nchem.2361Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4618406Citation Count: 253
- Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotes2014OPENTitle: Comparison of Parkinson Risk in Ashkenazi Jewish Patients With Gaucher Disease andGBAHeterozygotesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 6Start Page: 752End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.313Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4082726Citation Count: 191
-
OPENTitle: Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 3Start Page: e91190End Page: e91190Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0091190Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0091190&type=printableCitation Count: 30
-
OPENTitle: Mechanism and regulation of the Lys6-selective deubiquitinase USP30Journal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 11Start Page: 920End Page: 930Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nsmb.3475Best OA location URL: http://doi.org/10.1038/nsmb.3475Citation Count: 201
- A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia2013OPENTitle: A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystoniaJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 12Start Page: 1699End Page: 1707Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-1048-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-1048-3.pdfCitation Count: 65
- Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasm2013OPENTitle: Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin®) injections in blepharospasmJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 9Start Page: 1345End Page: 1353Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-013-0998-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-013-0998-9.pdfCitation Count: 60